Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days

Prolonged treatment with linezolid (LZD) is known to cause thrombocytopenia. However, some patients do not develop thrombocytopenia despite long-term administration of LZD. To determine the risk factors for LZD-associated thrombocytopenia in patients undergoing long-term LZD therapy, we conducted a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nagoya journal of medical science 2020-08, Vol.82 (3), p.407-414
Hauptverfasser:	Sato, Yoshitaka, Iguchi, Mitsutaka, Kato, Yoshiaki, Morioka, Hiroshi, Hirabayashi, Aki, Tetsuka, Nobuyuki, Tomita, Yuka, Kato, Daizo, Yamada, Kiyofumi, Kimura, Hiroshi, Yagi, Tetsuya
Format:	Artikel
Sprache:	eng
Schlagworte:	Original Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!